Athalit 50 Capsule contains Thalidomide 50mg, an effective immunomodulator used in multiple myeloma, inflammatory disorders, and certain autoimmune conditions. The capsule form ensures accurate dosing and patient compliance, especially in long-term therapy.
Thalidomide works by modulating the immune system, reducing inflammation, and inhibiting abnormal cell proliferation, making it valuable in hematological and inflammatory conditions.
From a business perspective, Athalit 50 Capsule is a specialty product with high demand in hospitals and oncology clinics, providing franchise partners with reliable orders and recurring prescriptions. Its clinical significance ensures strong prescriber confidence.
Adding Athalit 50 Capsule to your portfolio enhances your immunomodulatory and specialty therapy range, offering profitable growth, market stability, and long-term business opportunities in the oncology and immunotherapy segment.